Explorer les evidences

Oral artemisinin derivative treatments for uncomplicated P. falciparum malaria are associated with a transient and clinically moderate haemoglobin decrease by day 7.

Malipaludismeobservé day 7publié 2014Malaria journaleurope_pmcdocument de 4 observationsDOI 10.1186/1475-2875-13-358

30 %The mean proportion of severe malaria cases reported between 2017 and 2022 was 30%.

Malipaludismeobservé 2017–2022HAL · Unilimdocument de 111 observations

3 204 130 casesBetween 2021 and 2022, the number of malaria cases in Mali rose from 3,204,130 to 3,770,000.

Malipaludismeobservé 2021HAL · Unilimdocument de 111 observations

29 joursYoung et Burgess ont rapporté une période pré-patente de 29 jours pour P. malariae.

MalipaludismeHAL · Unilimdocument de 214 observations

28,7 %Malaria infection prevalence was 28.7% in 2012 among children in the health district of Koutiala, Mali.

Malipaludismeobservé 2012publié 2020International journal of environmental research and public healtheurope_pmcdocument de 7 observationsDOI 10.3390/ijerph17186639

Au Mali, le paludisme est saisonnier avec un pic d'incidence des cas cliniques et de mortalité entre septembre et novembre.

Malipaludismeobservé septembre-novembreHAL · Unilimdocument de 214 observations

1,9 per_1000SMC was associated with a 1.9 ‰ reduction in malaria incidence in the general population of Mali.

MalipaludismeHAL · Unilimdocument de 111 observations

28,5 %Parmi 28 échantillons examinés, les schizontes ont été trouvés dans 8 échantillons, soit 28,5 %.

MalipaludismeHAL · Unilimdocument de 214 observations

70 %A pilot study conducted in the central region of Segou found indoor residual spraying (IRS) reduced malaria incidence by 70%.

MalipaludismeHAL · Unilimdocument de 111 observations

66,8 %Hospital admissions for WHO-defined severe malaria were reduced by 66.8% in the combined RTS,S/AS01 E and SMC group compared with the SMC alone group.

Malipaludismepublié 2024The Lancet. Infectious diseaseseurope_pmcdocument de 12 observationsDOI 10.1016/s1473-3099(23)00368-7

3 %Le Mali contribue à 3 % des cas et décès mondiaux dus au paludisme.

MalipaludismeHAL · Unilimdocument de 214 observations

0,944 nMP. ovale isolates showed no significant difference in susceptibility to cabamiquine compared to P. falciparum, with a median IC50 of 0.9441 nM.

Malipaludismepublié 2026BMC infectious diseaseseurope_pmcdocument de 4 observations

37 372 parasites/μLLa parasitémie moyenne pour les infections à Plasmodium falciparum chez les individus symptomatiques était de 37 372 parasites/μL.

MalipaludismeHAL · Unilimdocument de 214 observations

28,5 %Among children with sickle cell trait in Mali, the prevalence of severe versus uncomplicated malaria in heterozygous females with the G6PD (A−) polymorphism was 28.5%.

MaliG6PD (A−) polymorphism · paludisme · trait drépanocytairepublié 2011American Journal of HematologyOpenAlexdocument de 9 observationsDOI 10.1002/ajh.22093

77,4 %Cross-reactive antibodies against S were present in 77.4% of BS− samples (42 out of 62).

MalipaludismeHAL · Unilimdocument de 67 observations

2 951 036 testsOver the 2018–2022 period, 15% (2,951,036) of suspected malaria cases in Mali were tested by thick blood smear microscopy.

Malipaludismeobservé 2018–2022HAL · Unilimdocument de 111 observations

78,2 %In Part B of the trial, Plasmodium falciparum infections were detected on blood-smear examination in 86 participants (78.2%) who received placebo.

Malipaludismepublié 2022The New England journal of medicineeurope_pmcdocument de 5 observations

Artemether-lumefantrine showed comparable therapeutic efficacy in children without severe acute malnutrition and in those with severe acute malnutrition when given in combination with ready-to-use therapeutic food.

Malipaludismepublié 2016BMC medicineeurope_pmcdocument de 5 observations

5,64 %La fréquence de Plasmodium malariae était plus élevée chez les participants asymptomatiques (5,64 %) que chez ceux présentant des symptômes cliniques (2,45 %).

MalipaludismeHAL · Unilimdocument de 214 observations

78,5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 78.5% showed a 2-fold increase in anti-CSP IgG antibody titres post-2021 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobservé post-2021HAL · Unilimdocument de 105 observations

92,9 %The level of Plasmodium falciparum clinical response to Artesunate-Amodiaquine was 92.9% (156/168) of Adequate Clinical and Parasitological Response before molecular correction.

Malipaludismepublié 2021The Journal of parasitologyeurope_pmcdocument de 8 observations

12,4 %Malaria infection prevalence was 12.4% in 2014 among children in the health district of Koutiala, Mali.

Malipaludismeobservé 2014publié 2020International journal of environmental research and public healtheurope_pmcdocument de 7 observationsDOI 10.3390/ijerph17186639

0,9 %For the final 16-month follow-up period, vaccine efficacy was 0.9% against all malaria episodes.

Malipaludismepublié 2013PloS oneeurope_pmcdocument de 2 observations

65,2 %Malaria prevalence from all Plasmodium species was 65.20% in passive screening.

Malipaludismepublié 2023Tropical medicine and infectious diseaseeurope_pmcdocument de 16 observations

25 childrenPlasmodium vivax was detected in 25 Duffy-negative children in Bandiagara, Mali.

Malipaludismepublié 2017The American journal of tropical medicine and hygieneeurope_pmcdocument de 4 observations